Contact
Please use this form to send email to PR contact of this press release:
Ractigen Therapeutics Announces Dosing of First Patient in First in Human Trial of RAG-17 for the Treatment of SOD1-ALS
TO:
Please use this form to send email to PR contact of this press release:
Ractigen Therapeutics Announces Dosing of First Patient in First in Human Trial of RAG-17 for the Treatment of SOD1-ALS
TO: